Find out more about Kindeva’s new sterile fill-finish facility in Bridgeton. In this video, John Wichelt, Vice President & General Manager, Bridgeton, Kindeva, discusses the site’s capabilities, how it supports injectable programs from clinical development through commercial manufacturing, and its approach to technology transfer. He also shares his perspective on choosing a long-term fill-finish partner and the changing needs of injectable drug developers.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
